Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line
- 18 October 1999
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 58 (10) , 1529-1537
- https://doi.org/10.1016/s0006-2952(99)00237-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Isolation and Characterization of Thymitaq (AG337) and 5-Fluoro-2-deoxyuridylate-resistant Mutants of Human Thymidylate Synthase from Ethyl Methanesulfonate-exposed Human Sarcoma HT1080 CellsPublished by Elsevier ,1998
- A Hydroxyl Group at Residue 216 Is Essential for Catalysis by Human Thymidylate SynthaseBiochemistry, 1998
- Thymineless death in colon carcinoma cells is mediated via Fas signalingProceedings of the National Academy of Sciences, 1997
- THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASEAnnual Review of Biochemistry, 1995
- Metabolism and mechanism of action of 5-fluorouracilPharmacology & Therapeutics, 1990
- Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.Proceedings of the National Academy of Sciences, 1989
- Nucleotide sequence of a functional cDNA for human thymidylate synthaseNucleic Acids Research, 1985
- Mutants of chinese hamster cells deficient in thymidylate synthetaseJournal of Cellular Physiology, 1984
- Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant ehrlich ascites carcinoma cellsBiochemical Pharmacology, 1983
- Selection of mammalian thymidine auxotrophic cell mutants defective in thymidylate synthase by their reduced sensitivity to methotrexateSomatic Cell and Molecular Genetics, 1981